FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Christine Chevreau

Research Profile

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Aurore Blesius; Christine Chevreau; Stéphane Oudard; Alain Ravaud; Frédéric Rolland; Benoit Beuselinck; Bernard Escudier
Are Tyrosine Kinase Inhibitors Still Active in Patients With Metastatic Renal Cell Carcinoma Previously Treated With a Tyrosine Kinase Inhibitor and Everolimus? Experience of 36 Patients Treated in France in the RECORD-1 Trial.
Anna Patrikidou; D Pérol; ISABELLE RAY COQUARD; M Rios; Antoine Adenis; F Bertucci; Jean-Yves Blay; Binh Nguyen Bui; Sylvie Chabaud; Christine Chevreau; Didier Cupissol; Julien Domont; Florence Duffaud; Axel Le Cesne
Influence of imatinib interruption and rechallenge on the residual disease in patients with advanced GIST: results of the BFR14 prospective French Sarcoma Group randomised, phase III trial.
Antoine Italiano; Marick Laë; Philippe Lagarde; Axel Le Cesne; Bernard Marques; Jean-Jacques Michels; Nicolas Penel; Sophie Piperno-Neumann; Dominique Ranchere-Vince; Philippe Terrier; Martine Trassard; Jacques-Olivier Bay; Jean-Yves Blay; Sylvie Bonvalot; Céline Brulard; Christine Chevreau; Angela Cioffi; Jean-Michel Coindre; Corinne Delcambre; Nicolas Isambert; Frédéric Chibon
Genetic profiling identifies two classes of soft-tissue leiomyosarcomas with distinct clinical characteristics.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Christine Chevreau (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Aurore Blesius; Christine Chevreau; Stéphane Oudard; Alain Ravaud; Frédéric Rolland; Benoit Beuselinck; Bernard Escudier
Are Tyrosine Kinase Inhibitors Still Active in Patients With Metastatic Renal Cell Carcinoma Previously Treated With a Tyrosine Kinase Inhibitor and Everolimus? Experience of 36 Patients Treated in France in the RECORD-1 Trial.
Clinical genitourinary cancer 2013;11(2):128-33.
2013: Anna Patrikidou; D Pérol; ISABELLE RAY COQUARD; M Rios; Antoine Adenis; F Bertucci; Jean-Yves Blay; Binh Nguyen Bui; Sylvie Chabaud; Christine Chevreau; Didier Cupissol; Julien Domont; Florence Duffaud; Axel Le Cesne
Influence of imatinib interruption and rechallenge on the residual disease in patients with advanced GIST: results of the BFR14 prospective French Sarcoma Group randomised, phase III trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013;24(4):1087-93.
2013: Antoine Italiano; Marick Laë; Philippe Lagarde; Axel Le Cesne; Bernard Marques; Jean-Jacques Michels; Nicolas Penel; Sophie Piperno-Neumann; Dominique Ranchere-Vince; Philippe Terrier; Martine Trassard; Jacques-Olivier Bay; Jean-Yves Blay; Sylvie Bonvalot; Céline Brulard; Christine Chevreau; Angela Cioffi; Jean-Michel Coindre; Corinne Delcambre; Nicolas Isambert; Frédéric Chibon
Genetic profiling identifies two classes of soft-tissue leiomyosarcomas with distinct clinical characteristics.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013;19(5):1190-6.
2012: Antoine Adenis; Jacques-Olivier Bay; François Bertucci; Jean-Yves Blay; Olivier Bouché; Philippe Cassier; Christine Chevreau; Stéphanie Clisant; Olivier Collard; Charles Fournier; Antoine Italiano; Elsa Kalbacher; Andrew Kramar; Nicolas Penel
Serum creatine kinase increase in patients treated with tyrosine kinase inhibitors for solid tumors.
Medical oncology (Northwood, London, England) 2012;29(4):3003-8.
2012: Antoine Italiano; Elsa Kalbacher; Matteo Giaj Levra; ROBERT G MAKI; Nicolas Penel; Cristina Antonescu; François Bertucci; Jean-Yves Blay; Binh Bui; Christine Chevreau; Angela Cioffi; David R D'Adamo; Corinne Delcambre; Nicolas Isambert; Mary-Louise Keohan
Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas.
Cancer 2012;118(13):3330-6.
2012: Vincent Sibaud; Christine Chevreau; Jean-Pierre Delord; D Gangloff; I Garrido-Stowhas
[Dermatologic adverse events of the new targeted anticancer therapies used in oncodermatology].
Annales de chirurgie plastique et esthétique 2012;57(2):106-13.
2012: B Bui-Nguyen; Christine Chevreau; Jean-Michel Coindre; D Cupissol; A Italiano; M Jimenez; J P Lotz; Simone Mathoulin-Pélissier; N Penel; ISABELLE RAY COQUARD; A Thyss; J O Bay; Jean-Yves Blay; Françoise Bonichon
High-dose chemotherapy consolidation for chemosensitive advanced soft tissue sarcoma patients: an open-label, randomized controlled trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(3):777-84.
2012: ISABELLE RAY COQUARD; Yves-Marie Robin; Jacques-Olivier Bay; Jean-Yves Blay; Emmanuelle Bompas; Guilhem Bousquet; Christine Chevreau; Stéphanie Clisant; Olivier Collard; Didier Cupissol; Charles Fournier; Eric Gauthier; Nicolas Isambert; Antoine Italiano; Axel Le Cesne; Laurent Lemaitre; Nicolas Penel; Sophie Piperno-Neumann
Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF/GETO).
The oncologist 2012;17(2):260-6.
2011: Vincent Sibaud; Florence Dalenc; Loic Mourey; Christine Chevreau
Paronychia and pyogenic granuloma induced by new anticancer mTOR inhibitors.
Acta dermato-venereologica 2011;91(5):584-5.
2011: Sylvie Négrier; David Pérol; Frédéric Rolland; Emmanuel Sevin; Jacques-Olivier Bay; Ellen Blanc; Christine Chevreau; Rémi Delva; Céline Ferlay; Lionel Geoffrois; Gwenaelle Gravis; Brigitte Laguerre; Eric Legouffe; Bernard Escudier
Temsirolimus and bevacizumab, or sunitinib, or interferon alfa and bevacizumab for patients with advanced renal cell carcinoma (TORAVA): a randomised phase 2 trial.
The lancet oncology 2011;12(7):673-80.
2011: Vincent Sibaud; Christine Chevreau; Florence Dalenc; Jean-Pierre Delord; Jean-Louis Lacaze; Loïc Mourey; Nora Rahhali; Henri Roché; Charles Taïeb
HFS-14, a specific quality of life scale developed for patients suffering from hand-foot syndrome.
The oncologist 2011;16(10):1469-78.
2010: Axel Le Cesne; ISABELLE RAY COQUARD; Binh Nguyen Bui; Antoine Adenis; Maria Rios; François Bertucci; Florence Duffaud; Christine Chevreau; Didier Cupissol; Angela Cioffi; Jean-François Emile; Sylvie Chabaud; David Pérol; Jean-Yves Blay
Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial.
The lancet oncology 2010;11(10):942-9.
2010: A Dufresne; F Bertucci; N Penel; Axel Le Cesne; Binh Nguyen Bui; M Tubiana-Hulin; ISABELLE RAY COQUARD; Didier Cupissol; Christine Chevreau; David Perol; A Goncalves; M Jimenez; P P Bringuier; Jean-Yves Blay
Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis.
British journal of cancer 2010;103(4):482-5.
2010: Pierre Martel; I Garrido; Gwenael Ferron; D Gangloff; Christine Chevreau; V Maisongrosse; S Zerdoud; C Simon; T Chapman
[An individualized prognosis for truncal melanoma? A series of 77 cases].
Bulletin du cancer 2010;97(8):901-7.
2009: D Labarre; Richard Aziza; T Filleron; Martine Delannes; F Delaunay; B Marques; G Ferron; Christine Chevreau
Detection of local recurrences of limb soft tissue sarcomas: is magnetic resonance imaging (MRI) relevant?
European journal of radiology 2009;72(1):50-3.
2009: Jérôme Fayette; Nicolas Penel; Christine Chevreau; Jean-Yves Blay; Didier Cupissol; Antoine Thyss; Cécile Guillemet; Maria Rios; Frédéric Rolland; Pierre Fargeot; Jacques Olivier Bay; Simone Mathoulin-Pelissier; Jean-Michel Coindre; Binh Bui-Nguyen
Phase III trial of standard versus dose-intensified doxorubicin, ifosfamide and dacarbazine (MAID) in the first-line treatment of metastatic and locally advanced soft tissue sarcoma.
Investigational new drugs 2009;27(5):482-9.
2009: Bernard Escudier; Tim Eisen; Walter M Stadler; Cezary Szczylik; Stéphane Oudard; Michael Staehler; Sylvie Negrier; Christine Chevreau; Apurva A Desai; Frédéric Rolland; Tomasz Demkow; Thomas E Hutson; Martin Gore; Sibyl Anderson; Gloria Hofilena; Minghua Shan; Carol Pena; Chetan Lathia; Ronald M Bukowski
Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(20):3312-8.
2009: Benjamin Besse; Dominique Grunenwald; Aude Fléchon; Armelle Caty; Christine Chevreau; Stéphane Culine; Christine Théodore; Karim Fizazi
Nonseminomatous germ cell tumors: assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosis.
The Journal of thoracic and cardiovascular surgery 2009;137(2):448-52.
2008: Nicolas Penel; Binh Nguyen Bui; Jacques-Olivier Bay; Didier Cupissol; ISABELLE RAY COQUARD; Sophie Piperno-Neumann; Pierre Kerbrat; Charles Fournier; Sophie Taieb; Marta Jimenez; Nicolas Isambert; Frédéric Peyrade; Christine Chevreau; Emmanuelle Bompas; Etienne G C Brain; Jean-Yves Blay
Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(32):5269-74.
2008: Christine Theodore; Christine Chevreau; Y Yataqhene; Karim Fizazi; Jean-Pierre Delord; J-P Lotz; Lionel Geoffrois; Pierre Kerbrat; V Bui; A Flechon
A phase II multicenter study of oxaliplatin in combination with paclitaxel in poor prognosis patients who failed cisplatin-based chemotherapy for germ-cell tumors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(8):1465-9.
2008: Heidi H Kong; Vincent Sibaud; Maria L Chanco Turner; Tito Fojo; Thomas Hornyak; Christine Chevreau
Sorafenib-induced eruptive melanocytic lesions.
Archives of dermatology 2008;144(6):820-2.
2008: Patricia Pautier; M Gutierrez-Bonnaire; Annie Rey; I Sillet-Bach; Christine Chevreau; Pierre Kerbrat; Philippe Morice; Pierre Duvillard; Catherine Lhommé
Combination of bleomycin, etoposide, and cisplatin for the treatment of advanced ovarian granulosa cell tumors.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2008;18(3):446-52.
2008: Stéphane Culine; Andrew Kramar; Christine Théodore; Lionel Geoffrois; Christine Chevreau; Pierre Biron; Binh Bui Nguyen; JF Héron; Pierre Kerbrat; Armelle Caty; Rémi Delva; Pierre Fargeot; Karim Fizazi; Jeannine Bouzy; Jean Pierre Droz
Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(3):421-7.
2007: Bernard Escudier; Anna Pluzanska; Piotr Koralewski; Alain Ravaud; Sergio Bracarda; Cezary Szczylik; Christine Chevreau; Marek Filipek; Bohuslav Melichar; Emilio Bajetta; Vera Gorbunova; Jacques-Olivier Bay; Istvan Bodrogi; Agnieszka Jagiello-Gruszfeld; Nicola Moore
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial.
Lancet 2007;370(9605):2103-11.
2007: Sylvie Negrier; David Perol; Alain Ravaud; Christine Chevreau; Jacques-Olivier Bay; Rémi Delva; Emmanuel Sevin; Armelle Caty; Bernard Escudier
Medroxyprogesterone, interferon alfa-2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis: results of a randomized controlled trial.
Cancer 2007;110(11):2468-77.
2007: Eric Huyghe; Audrey Muller; Roger Mieusset; Louis Bujan; Jean-Marc Bachaud; Christine Chevreau; Pierre Plante; Patrick Thonneau
Impact of diagnostic delay in testis cancer: results of a large population-based study.
European urology 2007;52(6):1710-6.
2007: F Canizares; Ignacio Garrido; Christine Chevreau; Vincent Pinsolle; Jean-Louis Grolleau; Jean-Pierre Chavoin
[The chondrosarcoma of the hand: review of the literature about a case and a proposition of a decision-making therapeutic tree].
Annales de chirurgie plastique et esthétique 2007;52(6):609-15.
2007: Bernard Escudier; Toni K Choueiri; Stéphane Oudard; Cezary Szczylik; Sylvie Négrier; Alain Ravaud; Christine Chevreau; Peter Venner; Patrick Champagne; Daniel Croteau; Eric Dupont; Claude Hariton; Ronald M Bukowski
Prognostic factors of metastatic renal cell carcinoma after failure of immunotherapy: new paradigm from a large phase III trial with shark cartilage extract AE 941.
The Journal of urology 2007;178(5):1901-5.
2007: Leonardo Astudillo; Magali Lacroix-Triki; F Cousin; Christine Chevreau
[A rarely diagnosed paraneoplastic syndrome: cerebral venous thrombosis].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 2007;28(10):716-7.
2007: Aude Wagner; Ignacio Garrido; Gwenael Ferron; Christine Chevreau; Jean-Michel Lafosse; Jean-Louis Grolleau; Jean-Pierre Chavoin
Subungual melanoma: for a conservative approach on the thumb scale.
Annals of plastic surgery 2007;59(3):344-8.
2007: Catherine Mazerolles; Christine Chevreau
[Rare malignant tumours of the prostate].
Bulletin du cancer 2007;94(7 Suppl):F44-9.
2007: Stéphane Culine; Pierre Kerbrat; Andrew Kramar; Christine Théodore; Christine Chevreau; Lionel Geoffrois; Nguyen Binh Bui; Jean Pény; Armelle Caty; Rémi Delva; Pierre Biron; Karim Fizazi; Jeannine Bouzy; Jean Pierre Droz
Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(5):917-24.
2007: Jean Pierre Droz; Andrew Kramar; Pierre Biron; José-Luis Pico; Pierre Kerbrat; Jean Pény; Hervé Curé; Christine Chevreau; Christine Théodore; Jeannine Bouzy; Stéphane Culine
Failure of high-dose cyclophosphamide and etoposide combined with double-dose cisplatin and bone marrow support in patients with high-volume metastatic nonseminomatous germ-cell tumours: mature results of a randomised trial.
European urology 2007;51(3):739-46; discussion 747-8.
2007: Bernard Escudier; Tim Eisen; Walter M Stadler; Cezary Szczylik; Stéphane Oudard; Michael Siebels; Sylvie Negrier; Christine Chevreau; Ewa Solska; Apurva A Desai; Frédéric Rolland; Tomasz Demkow; Thomas E Hutson; Martin Gore; Scott Freeman; Brian Schwartz; Minghua Shan; Ronit Simantov; Ronald M Bukowski
Sorafenib in advanced clear-cell renal-cell carcinoma.
The New England journal of medicine 2007;356(2):125-34.
2006: Jacques-Olivier Bay; ISABELLE RAY COQUARD; Jérôme Fayette; Serge Leyvraz; Stephane Cherix; Sophie Piperno-Neumann; Christine Chevreau; Nicolas Isambert; Etienne Brain; Georges Emile; Axel Le Cesne; Angela Cioffi; Fabrice Kwiatkowski; Jean-Michel Coindre; Nguyon Binh Bui; Frédéric Peyrade; Nicolas Penel; Jean-Yves Blay
Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis.
International journal of cancer. Journal international du cancer 2006;119(3):706-11.
2006: Aude Fléchon; Karim Fizazi; Sophie Gourgou-Bourgade; Christine Théodore; Philippe Beuzeboc; Lionel Geoffrois; Nicolas Mottet; Christine Chevreau; Stéphane Culine
Gemcitabine and cisplatin after radical cystectomy for bladder cancer in an adjuvant setting: feasibility study from the Genito-Urinary Group of the French Federation of Cancer Centers.
Anti-cancer drugs 2006;17(6):705-8.
2006: Jacques-Olivier Bay; Frédérique Penault-Llorca; Alain Ravaud; Christine Chevreau; Sylvie Négrier; Bernard Escudier
[New entities in pathological classification and new therapeutic options in renal cell carcinoma].
Bulletin du cancer 2006;93(1):91-100.
2006: Carmen Llácer; Martine Delannes; Mathieu Minsat; Eberhard Stoeckle; Laurent Votron; Pierre Martel; Paul Bonnevialle; Binh Nguyen Bui; Christine Chevreau; Guy Kantor; Nicolas Daly-Schveitzer; Laurence Thomas
Low-dose intraoperative brachytherapy in soft tissue sarcomas involving neurovascular structure.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2006;78(1):10-6.
2005: Paul Bonnevialle; A Brouchet; Nicolas Sans; Christine Chevreau; H Roche
[Metastasis on previous hip arthroplasty: three cases].
Revue de chirurgie orthopédique et réparatrice de l'appareil moteur 2005;91(6):558-63.
2005: Sylvie Negrier; Frédéric Gomez; Jean-Yves Douillard; Alain Ravaud; Christine Chevreau; Murielle Buclon; David Perol; Christine Lasset; Bernard Escudier
Prognostic factors of response or failure of treatment in patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d'Immunothérapie.
World journal of urology 2005;23(3):161-5.
2005: Christine Chevreau; Fabienne Thomas; Corinne Couteau; Florence Dalenc; Loic Mourey; Etienne Chatelut
Ototoxicity of high-dose carboplatin.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(15):3649-50; author reply 3650-1.
2005: Leonardo Astudillo; Magali Lacroix-Triki; Gwenael Ferron; Frédéric Rolland; Véronique Maisongrosse; Christine Chevreau
Bilateral breast metastases from ewing sarcoma of the femur.
American journal of clinical oncology 2005;28(1):102-3.
2004: Laurence Moureau-Zabotto; Laurence Thomas; Binh Nguyen Bui; Christine Chevreau; Eberhard Stockle; Pierre Martel; Paul Bonneviale; Bernard Marques; Jean-Michel Coindre; Guy Kantor; Tomohiro Matsuda; Martine Delannes
Management of soft tissue sarcomas (STS) in first isolated local recurrence: a retrospective study of 83 cases.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2004;73(3):313-9.
2004: Laurence Moureau-Zabotto; L Thomas; Binh Nguyen Bui; Christine Chevreau; E Stockle; Pierre Martel; P Bonneviale; Bernard Marques; Jean-Michel Coindre; Guy Kantor; T Matsuda; Martine Delannes
[Management of soft tissue sarcomas in first isolated local recurrence: a retrospective study of 83 cases].
Cancer radiothérapie : journal de la Société française de radiothérapie oncologique 2004;8(5):279-87.
2004: Florent Puisset; Etienne Chatelut; Florence Dalenc; Florent Busi; Thierry CRESTEIL; Joëlle Azéma; Muriel Poublanc; Isabelle Hennebelle; Thierry Lafont; Christine Chevreau; Henri Roché
Dexamethasone as a probe for docetaxel clearance.
Cancer chemotherapy and pharmacology 2004;54(3):265-72.
2004: Christine Chevreau; Catherine Mazerolles; Michel Soulié; Marie-Hélène Gaspard; Loïc Mourey; Louis Bujan; Pierre Plante; Pascal Rischmann; Jean-Marc Bachaud; Bernard Malavaud
Long-term efficacy of two cycles of BEP regimen in high-risk stage I nonseminomatous testicular germ cell tumors with embryonal carcinoma and/or vascular invasion.
European urology 2004;46(2):209-14; discussion 214-5.
2004: Sylvie Negrier; David Perol; Christine Menetrier-Caux; Bernard Escudier; Marc Pallardy; Alain Ravaud; Jean-Yves Douillard; Christine Chevreau; Christine Lasset; Jean-Yves Blay; Michel Pallardy
Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: prognostic value of interleukin-6--from the Groupe Francais d'Immunotherapie.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(12):2371-8.
2004: Eric Huyghe; Tomohiro Matsuda; Myriam Daudin; Christine Chevreau; Jean-Marc Bachaud; Pierre Plante; Louis Bujan; Patrick Thonneau
Fertility after testicular cancer treatments: results of a large multicenter study.
Cancer 2004;100(4):732-7.
2003: xavier game; Michel Soulié; Sidi Moussouni; Daniel Roux; Ghislaine Escourrou; Christine Chevreau; Richard Aziza
Renal angiomyolipoma associated with rapid enlargement [correction of enlargment] and inferior vena caval tumor thrombus.
The Journal of urology 2003;170(3):918-9.
2003: Karim Fizazi; Frédéric Rolland; Christine Chevreau; Jean Pierre Droz; Dominique Mery-Mignard; Stéphane Culine; Bernard Escudier
A phase II study of irinotecan in patients with advanced renal cell carcinoma.
Cancer 2003;98(1):61-5.
2003: Andrés J M Ferreri; Jean-Yves Blay; Michele Reni; Felice Pasini; Michele Spina; Achille Ambrosetti; Antonello Calderoni; Andrea Rossi; Vittorio Vavassori; Annarita Conconi; liliana devizzi; Françoise Berger; Maurilio Ponzoni; Bettina Borisch; Marianne Tinguely; Michele Cerati; Mario Milani; Enrico Orvieto; Juvenal Sanchez; Christine Chevreau; Stefania Dell'Oro; Emanuele Zucca; Franco Cavalli
Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(2):266-72.
2002: Xavier Pivot; Christine Chevreau; Didier Cupissol; Alain Lortholary; Nguyen Binh Bui; Jean-Christophe Eymard; Jacques-Olivier Bay; Marie-Christine Baranzelli; Monica Mita; Laurence Barnouin; Jacqueline Savary; Antoine Thyss
Phase II trial of paclitaxel-epirubicin in patients with recurrent soft-tissue sarcoma.
American journal of clinical oncology 2002;25(6):561-4.
2002: Alain Ravaud; Rémi Delva; Fréderic Gomez; Christine Chevreau; Jean-Yves Douillard; Jean Peny; Bruno Coudert; Sylvie Négrier
Subcutaneous interleukin-2 and interferon alpha in the treatment of patients with metastatic renal cell carcinoma-Less efficacy compared with intravenous interleukin-2 and interferon alpha. Results of a multicenter Phase II trial from the Groupe Français d'Immunothérapie.
Cancer 2002;95(11):2324-30.
2002: Sylvie Négrier; Bernard Escudier; Frédéric Gomez; Jean-Yves Douillard; Alain Ravaud; Christine Chevreau; Murielle Buclon; D Pérol; Christine Lasset
Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d'Immunothérapie.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(9):1460-8.
2002: Bernard Escudier; Jean Pierre Droz; Frédéric Rolland; M J Terrier-Lacombe; G Gravis; Philippe Beuzeboc; B Chauvet; Christine Chevreau; Jean-Christophe Eymard; Thierry Lesimple; Yacine Merrouche; Stéphane Oudard; Frank Priou; C Guillemare; Sophie Gourgou; Stéphane Culine
Doxorubicin and ifosfamide in patients with metastatic sarcomatoid renal cell carcinoma: a phase II study of the Genitourinary Group of the French Federation of Cancer Centers.
The Journal of urology 2002;168(3):959-61.
2002: Sylvie Negrier; Jean-Yves Douillard; Frédéric Gomez; Christine Lasset; Christine Chevreau; Bernard Escudier
[Interleukin-2 and interferon in metastatic kidney cancer. Experience of the French Immunotherapy Group].
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie 2002;12(2):213-8.
2001: Alain Ravaud; Michèle Delaunay; Christine Chevreau; V Coulon; Marc Debled; C Bret-Dibat; F Courbon; Norbert Gualde; Binh Nguyen Bui
Granulocyte-macrophage colony-stimulating factor alone or with dacarbazine in metastatic melanoma: a randomized phase II trial.
British journal of cancer 2001;85(10):1467-71.
2001: Karim Fizazi; R J Amato; P Beuzeboc; N Petit; D Bouhour; A Thiss; Christine Rebischung; Christine Chevreau; Christopher J Logothetis; Jean Pierre Droz
Germ cell tumors in patients infected by the human immunodeficiency virus.
Cancer 2001;92(6):1460-7.
2001: jean leon lagrange; Alain Ramaioli; Christine Theodore; Marie-José Terrier-Lacombe; Véronique Beckendorf; Pierre Biron; Christine Chevreau; P Chinet-Charrot; J Dumont; A Delobel-Deroide; Joëlle d'Anjou; C Chassagne; R M Parache; J M Karsenty; J Mercier; Jean Pierre Droz
Non-Hodgkin's lymphoma of the testis: a retrospective study of 84 patients treated in the French anticancer centres.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(9):1313-9.
2000: Marie-Pierre Rols; Jean-Marc Bachaud; P Giraud; Christine Chevreau; Henri Roché; Justin Teissié
Electrochemotherapy of cutaneous metastases in malignant melanoma.
Melanoma research 2000;10(5):468-74.
2000: Bernard Malavaud; Catherine Mazerolles; E Bieth; Christine Chevreau; M A Le Frere; L Alric
Pure seminoma in a male phenotype 46,XX true hermaphrodite.
The Journal of urology 2000;164(1):125-6.
2000: Martine Delannes; L Thomas; Pierre Martel; Paul Bonnevialle; Eberhard Stoeckle; Christine Chevreau; Binh Nguyen Bui; Nicolas Daly-Schveitzer; J Pigneux; Guy Kantor
Low-dose-rate intraoperative brachytherapy combined with external beam irradiation in the conservative treatment of soft tissue sarcoma.
International journal of radiation oncology, biology, physics 2000;47(1):165-9.
2000: Etienne Chatelut; Xavier Pivot; Josiane Otto; Christine Chevreau; Antoine Thyss; Nicole Renée; Gérard Milano; Pierre Canal
A limited sampling strategy for determining carboplatin AUC and monitoring drug dosage.
European journal of cancer (Oxford, England : 1990) 2000;36(2):264-9.
1999: ISABELLE RAY COQUARD; A Le Cesne; M T Rubio; J Mermet; C Maugard; Alain Ravaud; Christine Chevreau; Catherine Sebban; Thomas Bachelot; Pierre Biron; J Y Blay
Risk model for severe anemia requiring red blood cell transfusion after cytotoxic conventional chemotherapy regimens. The Elypse 1 Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(9):2840-6.
1999: Jean-Marc Bachaud; F Berthier; Michel Soulié; Bernard Malavaud; Pierre Plante; Pascal Rischmann; Christine Chevreau; Pascale Grosclaude
[Risk of second non-germ cell cancer after treatment of stage I-II testicular seminoma].
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie 1999;9(4):689-95.
1999: Bernard Escudier; Christine Chevreau; Christine Lasset; Jean-Yves Douillard; Alain Ravaud; M Fabbro; Armelle Caty; Jean-François Rossi; Patrice Viens; Jean-Pierre Bergerat; Jacqueline Savary; Sylvie Négrier
Cytokines in metastatic renal cell carcinoma: is it useful to switch to interleukin-2 or interferon after failure of a first treatment? Groupe Français d'Immunothérape.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(7):2039-43.
1999: Christine Chevreau; B N Bui; Bernard Chevallier; I Krakowski; C Maugard; J Mihura; J M Coindre; B Gil; V Cour-Chabernaud
Phase I-II trial of intensification of the MAID regimen with support of lenograstim (rHuG-CSF) in patients with advanced soft-tissue sarcoma (STS).
American journal of clinical oncology 1999;22(3):267-72.
1999: Thierry Dorval; Sylvie Négrier; Christine Chevreau; M F Avril; D Baume; Didier Cupissol; R Oskam; R de Peuter; J Vinke; A Herrera; Bernard Escudier
Randomized trial of treatment with cisplatin and interleukin-2 either alone or in combination with interferon-alpha-2a in patients with metastatic melanoma: a Federation Nationale des Centres de Lutte Contre le Cancer Multicenter, parallel study.
Cancer 1999;85(5):1060-6.
1999: Jean-Marc Bachaud; F Berthier; Michel Soulié; Bernard Malavaud; Pierre Plante; Pascal Rischmann; Christine Chevreau; Nicolas Daly-Schveitzer; Pascale Grosclaude
Second non-germ cell malignancies in patients treated for stage I-II testicular seminoma.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1999;50(2):191-7.
1998: Alain Ravaud; Christine Chevreau; Laurent Cany; P Houyau; N Dohollou; Henri Roché; Pierre Soubeyran; Françoise Bonichon; J Mihura; Houchingue Eghbali; I Tabah; Binh Nguyen Bui
Granulocyte-macrophage colony-stimulating factor in patients with neutropenic fever is potent after low-risk but not after high-risk neutropenic chemotherapy regimens: results of a randomized phase III trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(9):2930-6.
1998: Alain Ravaud; Bruno Audhuy; F Gomez; Bernard Escudier; Thierry Lesimple; Christine Chevreau; Jean-Yves Douillard; Armelle Caty; Lionel Geoffrois; J M Ferrero; C Linassier; M Drevon; Sylvie Négrier
Subcutaneous interleukin-2, interferon alfa-2a, and continuous infusion of fluorouracil in metastatic renal cell carcinoma: a multicenter phase II trial. Groupe Français d'Immunothérapie.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(8):2728-32.
1998: J Y Blay; A Le Cesne; C Mermet; C Maugard; Alain Ravaud; Christine Chevreau; Catherine Sebban; J Guastalla; Pierre Biron; ISABELLE RAY COQUARD
A risk model for thrombocytopenia requiring platelet transfusion after cytotoxic chemotherapy.
Blood 1998;92(2):405-10.
1998: Sylvie Negrier; Bernard Escudier; Christine Lasset; Jean-Yves Douillard; Jacqueline Savary; Christine Chevreau; Alain Ravaud; A Mercatello; Jean Peny; Mireille Mousseau; T Philip; T Tursz
Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Français d'Immunothérapie.
The New England journal of medicine 1998;338(18):1272-8.
1998: J Y Blay; T Conroy; Christine Chevreau; Antoine Thyss; N Quesnel; Houchingue Eghbali; R Bouabdallah; Bertrand Coiffier; J P Wagner; A Le Mevel; D Dramais-Marcel; E Baumelou; Franck Chauvin; Pierre Biron
High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(3):864-71.
1998: Bernard Escudier; Alain Ravaud; D Berton; Christine Chevreau; J Y Douillard; P Y Dietrich
Phase II study of interferon-alpha and all-trans retinoic acid in metastatic renal cell carcinoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1998;21(1):62-4.
1998: L Nguyen; Etienne Chatelut; Christine Chevreau; Brigitte Tranchand; Isabelle Lochon; Jean-Marc Bachaud; A Pujol; G Houin; Roland Bugat; Pierre Canal
Population pharmacokinetics of total and unbound etoposide.
Cancer chemotherapy and pharmacology 1998;41(2):125-32.
1997: S Bénézet; Rosine Guimbaud; Etienne Chatelut; Christine Chevreau; Roland Bugat; Pierre Canal
How to predict carboplatin clearance from standard morphological and biological characteristics in obese patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(6):607-9.
1996: L Gladieff; P Houyau; J Mihura; M Martinez; N Caunes; Christine Chevreau; Roland Bugat; Henri Roché
[A phase II study with mitoxantrone-vinorelbine association in the treatment of advanced breast cancer in elderly women].
Bulletin du cancer 1996;83(9):703-6.
1996: Louis Bujan; Jean-Marc Bachaud; Christine Chevreau; F Pontonnier; A Mansat; Roger Mieusset
[Treatments of testicular cancer and protection of spermatogenesis].
Contraception, fertilité, sexualité (1992) 1996;24(7-8):596-602.
1996: Thierry Le Chevalier; D Brisgand; Jean-Louis Pujol; Jean-Yves Douillard; A Monnier; Alain Rivière; P Chomy; A Le Groumellec; P Ruffie; M Gottfried; M H Gaspard; Christine Chevreau; Vicente Alberola; S Cigolari; F Besson; A Martinez; M Besenval; P Berthaud; Thomas Tursz
[Results of a randomized study comparing combination of navelbine-cisplatin to combination of vindesine-cisplatin and to navelbine alone in 612 patients with inoperable non-small cell lung cancer].
Bulletin du cancer 1996;83(5):385-94.
1995: Etienne Chatelut; A Dezeuze; M Lavit; Christine Chevreau; A Pujol; A Boneu; Henri Roché; G Houin; Roland Bugat; Pierre Canal
[Prediction of carboplatin clearance from morphological and biological patient characteristics].
Bulletin du cancer 1995;82(11):946-53.
1995: Binh Nguyen Bui; B Chevallier; Christine Chevreau; I Krakowski; A M Peny; A Thyss; C Maugard-Louboutin; Didier Cupissol; Pierre Fargeot; Françoise Bonichon
Efficacy of lenograstim on hematologic tolerance to MAID chemotherapy in patients with advanced soft tissue sarcoma and consequences on treatment dose-intensity.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(10):2629-36.
1995: M Lavit; Christine Chevreau; Etienne Chatelut; V De Fenin; Isabelle Lochon; G Houin; Roland Bugat; Pierre Canal
[Relations between hematological toxicity and total and free plasma levels of etoposide in daily oral administration].
Bulletin du cancer 1995;82(8):660-4.
1995: Etienne Chatelut; Pierre Canal; V Brunner; Christine Chevreau; A Pujol; A Boneu; Henri Roché; G Houin; Roland Bugat
Prediction of carboplatin clearance from standard morphological and biological patient characteristics.
Journal of the National Cancer Institute 1995;87(8):573-80.
1995: Etienne Chatelut; Christine Chevreau; V Brunner; M Martinez; G Houin; Roland Bugat; Pierre Canal
A pharmacologically guided phase I study of carboplatin in combination with methotrexate and vinblastine in advanced urothelial cancer.
Cancer chemotherapy and pharmacology 1995;35(5):391-6.
1994: Bernard Escudier; Alain Ravaud; M Fabbro; Jean-Yves Douillard; Sylvie Négrier; Christine Chevreau; L Mignot; D Baume; Thierry Dorval; F Vignal
High-dose interleukin-2 two days a week for metastatic renal cell carcinoma: a FNCLCC multicenter study.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1994;16(4):306-12.
1994: L Thomas; Martine Delannes; E Stöckle; P Martel; Binh Nguyen Bui; Nicolas Daly-Schveitzer; J Pigneux; Christine Chevreau; Guy Kantor
Intraoperative interstitial iridium brachytherapy in the management of soft tissue sarcomas: preliminary results of a feasibility phase II study.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1994;33(2):99-105.
1993: M de Forni; V Gualano; Pierre Canal; P Martel; F Izar-Soum; Christine Chevreau; P Soulié; Henri Roché; Roland Bugat
[Continuous double administration of 5 fluorouracil (intravenous and intraperitoneal) modulated by folinic acid: phase I clinical study and pharmacokinetics in patients with intra-abdominal developing cancers].
Bulletin du cancer 1993;80(5):408-17.
1993: Christine Chevreau; J P Droz; J L Pico; P Biron; P Kerbrat; Hervé Cure; J F Héron; B Chevallier; Pierre Fargeot; A Kramar
Early intensified chemotherapy with autologous bone marrow transplantation in first line treatment of poor risk non-seminomatous germ cell tumours. Preliminary results of a French randomized trial.
European urology 1993;23(1):213-7; discussion 218.
1992: M de Forni; Myriam Malet-Martino; P Jaillais; R E Shubinski; Jean-Marc Bachaud; L Lemaire; Pierre Canal; Christine Chevreau; Didier Carrié; P Soulié
Cardiotoxicity of high-dose continuous infusion fluorouracil: a prospective clinical study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(11):1795-801.
1992: Jean-Marc Bachaud; R Shubinski; G Boussin; Christine Chevreau; J M David; R Viraben; J L Bonafé; N J Daly
Stage I cutaneous malignant melanoma: risk factors of loco-regional recurrence after wide local excision and clinical perspectives.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1992;18(5):442-8.
1991: Etienne Chatelut; M de Forni; Pierre Canal; Christine Chevreau; H Roche; Y Plusquellec; N P Johnson; Georges Houin; Roland Bugat
Teniposide and cisplatin given by intraperitoneal administration: preclinical and phase I/pharmacokinetic studies.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2(3):217-21.
1991: Pierre Canal; A Sqall; M de Forni; Christine Chevreau; A Pujol; Roland Bugat; H Roche; J Oustrin; Georges Houin
Chronopharmacokinetics of doxorubicin in patients with breast cancer.
European journal of clinical pharmacology 1991;40(3):287-91.
1991: M de Forni; S Lachau; F Huguet; Pierre Canal; G Laurent; Christine Chevreau; H Roche; Roland Bugat
Phase I/II pharmacokinetic study of mitoxantrone by continuous venous infusion in patients with solid tumours and lymphoproliferative diseases.
European journal of cancer (Oxford, England : 1990) 1991;27(6):735-9.
1990: M de Forni; Roland Bugat; F Sorbette; M Delay; Jean-Marc Bachaud; Christine Chevreau
[Cardiotoxicity of continuous intravenous infusion of 5-fluorouracil: clinical study, prevention and physiopathology. Apropos of 13 cases].
Bulletin du cancer 1990;77(5):429-38.
1990: Etienne Chatelut; Christine Chevreau; E Blancy; A Lequellec; Pierre Canal; H Roche; G Houin; R Bugat
Pharmacokinetics and toxicity of two modalities of etoposide infusion in metastatic non-small-cell lung carcinoma.
Cancer chemotherapy and pharmacology 1990;26(5):365-8.
1989: F Sorbette; H Roche; Christine Chevreau; M De Forni; R Bugat; A Mercadier
[Evaluation of fatal iatrogenic risk in cancerology].
Thérapie 1989;44(5):379.
1989: Roland Bugat; J Robert; A Herrera; M C Pinel; S Huet; Christine Chevreau; G Boussin; J Roquain; M Carton
Clinical and pharmacokinetic study of 96-h infusions of doxorubicin in advanced cancer patients.
European journal of cancer & clinical oncology 1989;25(3):505-11.
1989: Etienne Chatelut; Pierre Canal; M De Forni; Christine Chevreau; Georges Houin; Roland Bugat
[Phase I trial and pharmacokinetics of VM 26 combined with cisplatin administered by the intraperitoneal route without mixing time].
Bulletin du cancer 1989;76(8):893-6.
1989: Pierre Canal; Etienne Chatelut; M De Forni; Christine Chevreau; N Johnson; Georges Houin; Roland Bugat
[Comparison of the pharmacokinetics of cisplatin administered by the intraperitoneal route in 2 dosages: 100 and 200 mg/m2].
Bulletin du cancer 1989;76(8):879-82.
1989: Pierre Canal; M de Forni; Etienne Chatelut; Christine Chevreau; N P Johnson; Georges Houin; Roland Bugat
Clinical and pharmacokinetic study of intraperitoneal cisplatin at two dose levels: 100 mg/m2 alone or 200 mg/m2 with i.v. sodium thiosulfate.
Acta medica Austriaca 1989;16(3-4):84-6.